Author: Barnard, Karen N.; Wasik, Brian R.; LaClair, Justin R.; Buchholz, David W.; Weichert, Wendy S.; Alford-Lawrence, Brynn K.; Aguilar, Hector C.; Parrish, Colin R.
Title: Expression of 9-O- and 7,9-O-Acetyl Modified Sialic Acid in Cells and Their Effects on Influenza Viruses Document date: 2019_12_3
ID: 11ejfiwe_26
Snippet: In summary, we have shown that these modifications are present in different cell lines sourced from different species of animals, but they make up a small minority of the total Sia present. In addition, these modifications vary considerably in their localization and have an inherent heterogeneity within cell populations. While the presence of both 7,9-O-and 9-O-Ac were dependent on the activity of CasD1, the relative proportions, levels of expres.....
Document: In summary, we have shown that these modifications are present in different cell lines sourced from different species of animals, but they make up a small minority of the total Sia present. In addition, these modifications vary considerably in their localization and have an inherent heterogeneity within cell populations. While the presence of both 7,9-O-and 9-O-Ac were dependent on the activity of CasD1, the relative proportions, levels of expression, and localization appear to be controlled by more complex mechanisms than simply the expression of CasD1 and SIAE. How this regulated expression affects cell homeostasis is unknown, but it is likely relevant during development, immune responses, and in cancers that show dysregulation of 7,9-O-and 9-O-Ac expression. For viruses such as ICV and IDV that rely on 9-O-Ac for infection, the low levels seen on cell surfaces are sufficient for infection. We found that 7,9-O-and 9-O-Ac do have inhibitory activity on HA binding and NA cleavage when present at higher levels. Although these modifications are present on cell surfaces at levels too low to affect IAV and IBV infection, they are expressed at much higher levels in mucosal tissues and in secreted mucus proteins of many animals, which may provide a more effective barrier (10, 11, (51) (52) (53) . We are currently examining these processes for secreted mucus and other sources in different animals.
Search related documents:
Co phrase search for related documents- cell surface and considerably vary: 1
- cell surface and different animal: 1, 2, 3
- cell surface and expression level: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43
- cell surface and HA binding: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
- cell surface and high level: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23
- cell surface and IBV IAV infection: 1
- immune response and inhibitory activity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18
- immune response and low level: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45
- immune response and mucosal tissue: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
- immune response and mucus protein: 1
- immune response and regulated expression: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47
- immune response and small minority: 1
- immune response development and low level: 1
- immune response development and mucosal tissue: 1, 2
- immune response development and regulated expression: 1
- inhibitory activity and low level: 1
- inhibitory activity and NA cleavage: 1
- inhibitory activity and NA cleavage HA binding: 1
- inhibitory activity and Sia present: 1
Co phrase search for related documents, hyperlinks ordered by date